ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught

ASCO: Merck and its new multibillion-dollar partners hone plans for marketing onslaught

Source: 
Fierce Pharma
snippet: 

Merck, arguably the belle of the ball at this year’s American Society of Clinical Oncology annual meeting, spent its on-stage time with major new data for its immuno-oncology star, Keytruda. But behind the scenes, it was huddled up with teams from its new multibillion-dollar partners, AstraZeneca and Eisai.